NCT01512277View on ClinicalTrials.gov

Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

March 31, 1999

Study Completion Date

September 30, 1999

Conditions
SchistosomiasisBilharziasisUrinary Schistosomiasis
Interventions
BIOLOGICAL

rSh28GST

subcutaneous route at Day 0, Day 28, and Day 150 for the third administration of 100µg for Arm 1

Trial Locations (1)

59000

Centre d'Investigation Clinique - CHRU de Lille, Lille

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Lille

OTHER

NCT01512277 - Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis | Biotech Hunter | Biotech Hunter